20:27 :
Vernalis shares rise 28% after US cold medicine deal -
UK biotech firm's licensing deal on slow-release drugs with Tris Pharma sees £69m pledged in oversubscribed fundraisingShares in Vernalis have surged after the biotechnology firm sealed a key deal with US company Tris Pharma to develop ...